Clinical trial data from the SURMOUNT-1 study showed that gastrointestinal adverse events were significantly more common during dose escalation periods (Jastreboff et al., 2022, NEJM)
On the other hand, (ii) the first assessment of the analgesia in the absence of morphine (time "0"), the application of saline was administered 30 min in advance (time "-30 min"), the application of haloperidol or gastric pentadecapeptide BPC 157 or naloxone or saline 20 min in advance (time "-20 min"), and the application of saline 10 min in advance (time "-10 min")
A phased approach might start with immune modulation (KPV, potentially thymosin alpha-1) to calm the acute inflammatory response, then introduce tissue repair peptides (BPC-157, GHK-Cu) once the immune environment is more favorable for healing
Some patients report temporary fatigue, headache, or mild GI discomfort in the first 24 to 48 hours following an injection, particularly with their first dose
ATGL-catalyzed lipolysis regulates SIRT1 to control PGC-1/PPAR- signaling